A B C Figure 1(A-C): A. RetCam at time of presentation (Images by Leslie MacKeen) showing a macular tumor (IIRC group B). B- B-scan Ultrasound at time of presentation. Tumor height 2.37 mm and lateral measurement 5.48mm. (Bscan by Cynthia VandenHoven). C- Stereo-images at time of enucleation. Best viewed with stereoscope viewer to appreciate cystic nature of tumour and tumour height. The scars of attempted laser treatment can be appreciated at the temporal edge of the tumor with increased size of the tumor. (RetCam stereo image by Cynthia VandenHoven)

A B C Fig 2: Right Eye, Images of right eye tumors at presentation Photos by Leslie MacKeen A: RetCam fundus image of tumour in superonasal quadrant Photos by Leslie MacKeen B: RetCam fundus image of tumor in inferotemporal quadrant Photos by Elise Heon

A B C Fig 3 A: 80 deg RetCam fundus photo of tumor in Fig 2A Photos by Leslie MacKeen 3B: Handheld OCT of tumor A demonstrating intraretinal isodense tumour Photos by Leslie MacKeen 3C: RetCam fundus photo of tumor A 3 weeks post laser Photos by Cynthia VandenHoven

A B Figure 4(A-C): Schematic presentation of the timeline of retinoblastoma management using e-Cancer care Retinoblastoma software (eCCRB). (A) It represents the actual timeline of the reported child. (B) It represents the imaginary outline if enucleation was done at initial presentation. (C) It represents the imaginary timeline if salvage treatment was chosen. It can be observed that the frequency of EUA is less, No systemic chemotherapy is given with its potential complications and the duration of active treatment is longer if salvage treatment is opted for. C